Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Multidrug resistance-associated protein 4 in pharmacology: Overview of its contribution to pharmacokinetics, pharmacodynamics and pharmacogenetics

7 Jun 2019

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Transport and Resistance Mechanisms
Share to Pediatric Hepatobiliary Diseases and Treatments
Share to Pharmacological Effects and Toxicity Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31176778
DOI: 10.1016/j.lfs.2019.06.015

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Multidrug resistance-associated protein 4 in pharmacology: Overview of its contribution to pharmacokinetics, pharmacodynamics and pharmacogeneticsPMID 31176778Read ↗

The Pharmacological and Physiological Role of Multidrug-Resistant Protein 4Semantic proximity Read ↗

Personalized drug therapy with pharmacogenetics. Part 1: Pharmacokinetics.Semantic proximity Read ↗

Multidrug resistance: molecular mechanisms and clinical relevanceSemantic proximity Read ↗

ABC transporter superfamily. An updated overview, relevance in cancer multidrug resistance and perspectives with personalized medicineSemantic proximity Read ↗

Pharmacology, pharmacogenetics, and pharmacoepidemiology: three ps of individualized therapy.Semantic proximity Read ↗

Physiological, pharmacological and clinical features of the multidrug resistance protein 2Semantic proximity Read ↗

Update on drug transporter proteins in acute myeloid leukemia: Pathological implication and clinical settingSemantic proximity Read ↗

Multidrug resistance-associated proteins 3, 4, and 5Semantic proximity Read ↗

Pharmacogenetics of anti-cancer drugs: State of the art and implementation – recommendations of the French National Network of PharmacogeneticsSemantic proximity Read ↗

PharmGKB summary: very important pharmacogene information for cytochrome P450, family 2, subfamily C, polypeptide 8.Semantic proximity Read ↗

Pharmacogenomics influence on MDR1-associated cancer resistance and innovative drug delivery approaches: advancing precision oncologySemantic proximity Read ↗

Pharmacology of drugs that alter multidrug resistance in cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.